Status:
COMPLETED
Escitalopram in Schizophrenia in OCD- Open Label Study
Lead Sponsor:
BeerYaakov Mental Health Center
Collaborating Sponsors:
Lundbeck Israel
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compul...
Eligibility Criteria
Inclusion
- Patients who suffer from schizophrenia and OCD
Exclusion
- Substance abuse,
- Serious medical condintions,
- Being on SSRI treatment
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00456937
Start Date
July 1 2006
End Date
September 1 2008
Last Update
January 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beer Yaakov MHC
Beer Yaakov, Israel, 70350